ReP USP - Resultado da busca

Artigo de periodico
Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users (2024)
Fonseca, Arilton Martins; Santos, Rafael Guimarães dos ; Medeiros, Lívia Soman de ; Veiga, Thiago André Moura; Cassas, Fernando; Bruniera, Carla Poleselli; Rossi, Giordano Novak ; Bouso, José Carlos; Hallak, Jaime Eduardo Cecílio; Santos, Fabiana Pereira; Paranhos, Beatriz Aparecida Passos Bismara ; Yonamine, Maurício ; Rodrigues, Eliana
Fonte: European Archives of Psychiatry and Clinical Neuroscience. Unidades: FMRP, FCF
Assuntos: ALUCINOGÊNICOS, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Arilton Martins et al. Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users. European Archives of Psychiatry and Clinical Neuroscience, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s00406-024-01817-9. Acesso em: 24 ago. 2024.
APA
Fonseca, A. M., Santos, R. G. dos, Medeiros, L. S. de, Veiga, T. A. M., Cassas, F., Bruniera, C. P., et al. (2024). Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users. European Archives of Psychiatry and Clinical Neuroscience. doi:10.1007/s00406-024-01817-9
NLM
Fonseca AM, Santos RG dos, Medeiros LS de, Veiga TAM, Cassas F, Bruniera CP, Rossi GN, Bouso JC, Hallak JEC, Santos FP, Paranhos BAPB, Yonamine M, Rodrigues E. Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2024 ;[citado 2024 ago. 24 ] Available from: https://dx.doi.org/10.1007/s00406-024-01817-9
Vancouver
Fonseca AM, Santos RG dos, Medeiros LS de, Veiga TAM, Cassas F, Bruniera CP, Rossi GN, Bouso JC, Hallak JEC, Santos FP, Paranhos BAPB, Yonamine M, Rodrigues E. Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2024 ;[citado 2024 ago. 24 ] Available from: https://dx.doi.org/10.1007/s00406-024-01817-9
Artigo de periodico
Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts (2023)
Vicentini, Anna Beatriz; Rodrigues, Lucas Silva; Rossi, Giordano Novak ; Rocha, Juliana Mendes; Guerra, Lorena Terene Lopes; Reis, José Augusto Silva; Maekawa, Renan Massanobu; Osório, Flávia de Lima; Bouso, José Carlos; Santos, Fabiana Pereira; Paranhos, Beatriz Aparecida Passos Bismara ; Yonamine, Maurício ; Hallak, Jaime Eduardo Cecílio; Santos, Rafael Guimarães dos
Fonte: Psychoactives. Unidades: EERP, FMRP, FCF
Assuntos: ALUCINOGÊNICOS, ESTUDANTES UNIVERSITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICENTINI, Anna Beatriz et al. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts. Psychoactives, v. 2, p. 346–358, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/psychoactives2040022. Acesso em: 24 ago. 2024.
APA
Vicentini, A. B., Rodrigues, L. S., Rossi, G. N., Rocha, J. M., Guerra, L. T. L., Reis, J. A. S., et al. (2023). Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts. Psychoactives, 2, 346–358. doi:10.3390/psychoactives2040022
NLM
Vicentini AB, Rodrigues LS, Rossi GN, Rocha JM, Guerra LTL, Reis JAS, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts [Internet]. Psychoactives. 2023 ; 2 346–358.[citado 2024 ago. 24 ] Available from: https://dx.doi.org/10.3390/psychoactives2040022
Vancouver
Vicentini AB, Rodrigues LS, Rossi GN, Rocha JM, Guerra LTL, Reis JAS, Maekawa RM, Osório F de L, Bouso JC, Santos FP, Paranhos BAPB, Yonamine M, Hallak JEC, Santos RG dos. Subjective effects of a single dose of Ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts [Internet]. Psychoactives. 2023 ; 2 346–358.[citado 2024 ago. 24 ] Available from: https://dx.doi.org/10.3390/psychoactives2040022
Artigo de periodico
Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] (2022)
Poli Netto, Omero Benedicto ; Hallak, Jaime Eduardo Cecílio; Rosa e Silva, Júlio César; Crippa, José Alexandre de Souza
Fonte: Revista Brasileira de Ginecologia e Obstetricia. Unidade: FMRP
Assuntos: CANNABIS, ENDOMETRIOSE, FARMACOTERAPIA, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLI NETTO, Omero Benedicto et al. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, v. 44, n. 5, p. 449-451, 2022Tradução . . Disponível em: https://doi.org/10.1055/s-0042-1749430. Acesso em: 24 ago. 2024.
APA
Poli Netto, O. B., Hallak, J. E. C., Rosa e Silva, J. C., & Crippa, J. A. de S. (2022). Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, 44( 5), 449-451. doi:10.1055/s-0042-1749430
NLM
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1055/s-0042-1749430
Vancouver
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1055/s-0042-1749430
Artigo de periodico
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials (2022)
Santos, Rafael Guimarães dos ; Rocha, Juliana Mendes; Rossi, Giordano Novak ; Osório, Flávia de Lima ; Ona, Genís ; Bouso, José Carlos ; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Marchioni, Camila ; Crevelin, Eduardo José ; Queiroz, Maria Eugênia Costa ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecílio
Fonte: Human Psychopharmacology. Unidades: FMRP, FCF, FFCLRP
Assuntos: ALUCINOGÊNICOS, ANSIEDADE SOCIAL, TRANSTORNOS DA ANSIEDADE, CHÁ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Human Psychopharmacology, v. 37, n. 4, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1002/hup.2834. Acesso em: 24 ago. 2024.
APA
Santos, R. G. dos, Rocha, J. M., Rossi, G. N., Osório, F. de L., Ona, G., Bouso, J. C., et al. (2022). Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Human Psychopharmacology, 37( 4), 1-5. doi:10.1002/hup.2834
NLM
Santos RG dos, Rocha JM, Rossi GN, Osório F de L, Ona G, Bouso JC, Silveira G de O, Yonamine M, Marchioni C, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials [Internet]. Human Psychopharmacology. 2022 ; 37( 4): 1-5.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1002/hup.2834
Vancouver
Santos RG dos, Rocha JM, Rossi GN, Osório F de L, Ona G, Bouso JC, Silveira G de O, Yonamine M, Marchioni C, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials [Internet]. Human Psychopharmacology. 2022 ; 37( 4): 1-5.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1002/hup.2834
Artigo de periodico
Acute effects of ayahuasca in a juvenile non-human primate model of depression (2019)
Silva, Flávia S. da; Silva, Erick A. S.; Sousa Jr., Geovan M. de; Oliveira, João P. Maia de; Rachetti, Vanessa de Paula Soares; Araujo, Draulio B. de; Sousa, Maria B. C.; Soares, Bruno Lobão; Hallak, Jaime Eduardo Cecílio; Coelho, Nicole L. Galvão
Fonte: Brazilian Journal of Psychiatry. Unidade: FMRP
Assuntos: PRIMATAS, SAGUIS, CORTISOL, DEPRESSÃO, FÁRMACOS SINTÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Flávia S. da et al. Acute effects of ayahuasca in a juvenile non-human primate model of depression. Brazilian Journal of Psychiatry, 2019Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2018-0140. Acesso em: 24 ago. 2024.
APA
Silva, F. S. da, Silva, E. A. S., Sousa Jr., G. M. de, Oliveira, J. P. M. de, Rachetti, V. de P. S., Araujo, D. B. de, et al. (2019). Acute effects of ayahuasca in a juvenile non-human primate model of depression. Brazilian Journal of Psychiatry. doi:10.1590/1516-4446-2018-0140
NLM
Silva FS da, Silva EAS, Sousa Jr. GM de, Oliveira JPM de, Rachetti V de PS, Araujo DB de, Sousa MBC, Soares BL, Hallak JEC, Coelho NLG. Acute effects of ayahuasca in a juvenile non-human primate model of depression [Internet]. Brazilian Journal of Psychiatry. 2019 ;[citado 2024 ago. 24 ] Available from: https://doi.org/10.1590/1516-4446-2018-0140
Vancouver
Silva FS da, Silva EAS, Sousa Jr. GM de, Oliveira JPM de, Rachetti V de PS, Araujo DB de, Sousa MBC, Soares BL, Hallak JEC, Coelho NLG. Acute effects of ayahuasca in a juvenile non-human primate model of depression [Internet]. Brazilian Journal of Psychiatry. 2019 ;[citado 2024 ago. 24 ] Available from: https://doi.org/10.1590/1516-4446-2018-0140
Artigo de periodico
Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness (2019)
Hamill, Jonathan; Hallak, Jaime Eduardo Cecílio; Dursun, Serdar M.; Baker, Glen
Fonte: Current Neuropharmacology. Unidade: FMRP
Assuntos: ALUCINOGÊNICOS, NEUROFARMACOLOGIA, TRANSTORNOS MENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAMILL, Jonathan et al. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, v. 17, n. 2, p. 108-128, 2019Tradução . . Disponível em: https://doi.org/10.2174/1570159x16666180125095902. Acesso em: 24 ago. 2024.
APA
Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. (2019). Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 17( 2), 108-128. doi:10.2174/1570159x16666180125095902
NLM
Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 ago. 24 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
Vancouver
Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 ago. 24 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
Artigo de periodico
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma (2019)
Vuolo, Francieli; Abreu, Soraia Carvalho; Michels, Monique; Xisto, Débora Gonçalves; Blanco, Natália G.; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Reis, Cardine Martins dos; Bahl, Marina; Pizzichinni, Emílio; Maurici, Rosemeri; Pizzichini, Márcia Margaret Menezes; Rocco, Patricia Rieken Macedo; Dal-Pizzol, Felipe
Fonte: European Journal of Pharmacology. Unidade: FMRP
Assuntos: ASMA, CANABINOIDES, FIBROSE PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUOLO, Francieli et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, v. 843, p. 251-259, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2018.11.029. Acesso em: 24 ago. 2024.
APA
Vuolo, F., Abreu, S. C., Michels, M., Xisto, D. G., Blanco, N. G., Hallak, J. E. C., et al. (2019). Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, 843, 251-259. doi:10.1016/j.ejphar.2018.11.029
NLM
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029
Vancouver
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029
Artigo de periodico
Serotonergic psychedelics and personality: a systematic review of contemporary research (2018)
Bouso, José Carlos; Santos, Rafael G. dos; Alcázar-Córcoles, Miguel Ángel; Hallak, Jaime Eduardo Cecílio
Fonte: Neuroscience and Biobehavioral Reviews. Unidade: FMRP
Assuntos: CÉREBRO, ALUCINOGÊNICOS, PERSONALIDADE, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOUSO, José Carlos et al. Serotonergic psychedelics and personality: a systematic review of contemporary research. Neuroscience and Biobehavioral Reviews, v. 87, p. 118-132, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2018.02.004. Acesso em: 24 ago. 2024.
APA
Bouso, J. C., Santos, R. G. dos, Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018). Serotonergic psychedelics and personality: a systematic review of contemporary research. Neuroscience and Biobehavioral Reviews, 87, 118-132. doi:10.1016/j.neubiorev.2018.02.004
NLM
Bouso JC, Santos RG dos, Alcázar-Córcoles MÁ, Hallak JEC. Serotonergic psychedelics and personality: a systematic review of contemporary research [Internet]. Neuroscience and Biobehavioral Reviews. 2018 ; 87 118-132.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.neubiorev.2018.02.004
Vancouver
Bouso JC, Santos RG dos, Alcázar-Córcoles MÁ, Hallak JEC. Serotonergic psychedelics and personality: a systematic review of contemporary research [Internet]. Neuroscience and Biobehavioral Reviews. 2018 ; 87 118-132.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.neubiorev.2018.02.004
Artigo de periodico
Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system (2018)
Schonhofen, Patrícia; Bristot, Ivi Juliana; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Parsons, Richard B.; Klamt, Fábio
Fonte: CNS Drugs. Unidade: FMRP
Assuntos: CANNABIS, TERAPÊUTICA MÉDICA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHONHOFEN, Patrícia et al. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, v. 32, n. 8, p. 697-712, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40263-018-0550-4. Acesso em: 24 ago. 2024.
APA
Schonhofen, P., Bristot, I. J., Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018). Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, 32( 8), 697-712. doi:10.1007/s40263-018-0550-4
NLM
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Vancouver
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Artigo de periodico
Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study (2018)
Oliveira, Icaro Agenor Ferreira de; Guimarães, Tiago M.; Souza, Roberto Molina de; Santos, Antônio Carlos dos; Machado-de-Sousa, João Paulo; Hallak, Jaime Eduardo Cecílio; Leoni, Renata Ferranti
Fonte: Psychiatry Research: Neuroimaging. Unidades: FMRP, FFCLRP
Assuntos: ESQUIZOFRENIA, FLUXO SANGUÍNEO REGIONAL, CÉREBRO, NEUROIMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Icaro Agenor Ferreira de et al. Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study. Psychiatry Research: Neuroimaging, v. 272, p. 71-78, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pscychresns.2017.12.001. Acesso em: 24 ago. 2024.
APA
Oliveira, I. A. F. de, Guimarães, T. M., Souza, R. M. de, Santos, A. C. dos, Machado-de-Sousa, J. P., Hallak, J. E. C., & Leoni, R. F. (2018). Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study. Psychiatry Research: Neuroimaging, 272, 71-78. doi:10.1016/j.pscychresns.2017.12.001
NLM
Oliveira IAF de, Guimarães TM, Souza RM de, Santos AC dos, Machado-de-Sousa JP, Hallak JEC, Leoni RF. Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study [Internet]. Psychiatry Research: Neuroimaging. 2018 ; 272 71-78.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.pscychresns.2017.12.001
Vancouver
Oliveira IAF de, Guimarães TM, Souza RM de, Santos AC dos, Machado-de-Sousa JP, Hallak JEC, Leoni RF. Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study [Internet]. Psychiatry Research: Neuroimaging. 2018 ; 272 71-78.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.pscychresns.2017.12.001
Artigo de periodico
Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos (2018)
Brigante, Tamires Amabile Valim; Abe, Flavia Renata; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Oliveira, Danielle Palma de
Fonte: Chemico-Biological Interactions. Unidades: FMRP, FCFRP
Assuntos: ACETILCOLINA, CANABINOIDES, ATIVIDADE MOTORA, TERATOGÊNIOS, FERTILIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIGANTE, Tamires Amabile Valim et al. Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos. Chemico-Biological Interactions, v. 291, p. 81-86, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2018.06.008. Acesso em: 24 ago. 2024.
APA
Brigante, T. A. V., Abe, F. R., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Oliveira, D. P. de. (2018). Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos. Chemico-Biological Interactions, 291, 81-86. doi:10.1016/j.cbi.2018.06.008
NLM
Brigante TAV, Abe FR, Zuardi AW, Hallak JEC, Crippa JA de S, Oliveira DP de. Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos [Internet]. Chemico-Biological Interactions. 2018 ; 291 81-86.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.cbi.2018.06.008
Vancouver
Brigante TAV, Abe FR, Zuardi AW, Hallak JEC, Crippa JA de S, Oliveira DP de. Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos [Internet]. Chemico-Biological Interactions. 2018 ; 291 81-86.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.cbi.2018.06.008
Artigo de periodico
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol (2018)
Silva, Vanessa Kappel da; Freitas, Betânia Souza de; Dornelles, Victória Campos; Kist, Luiza Wilges; Bogo, Maurício Reis; Silva, Milena Carvalho; Streck, Emílio Luiz; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Schröder, Nadja
Fonte: Brain Research Bulletin. Unidade: FMRP
Assuntos: CANABINOIDES, MITOCÔNDRIAS, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vanessa Kappel da et al. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, v. 139, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.brainresbull.2018.01.014. Acesso em: 24 ago. 2024.
APA
Silva, V. K. da, Freitas, B. S. de, Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., et al. (2018). Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, 139, 1-8. doi:10.1016/j.brainresbull.2018.01.014
NLM
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Vancouver
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Artigo de periodico
Psychedelics and Personality (2018)
Aixalà, Marc; Santos, Rafael G. dos; Hallak, Jaime Eduardo Cecílio; Bouso, José Carlos
Fonte: ACS Chemical Neuroscience. Unidade: FMRP
Assuntos: PERSONALIDADE, ALUCINOGÊNICOS, ANSIEDADE, SUBSTÂNCIAS NOCIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIXALÀ, Marc et al. Psychedelics and Personality. ACS Chemical Neuroscience, v. 9, n. 10, p. 2304-2306, 2018Tradução . . Disponível em: https://doi.org/10.1021/acschemneuro.8b00237. Acesso em: 24 ago. 2024.
APA
Aixalà, M., Santos, R. G. dos, Hallak, J. E. C., & Bouso, J. C. (2018). Psychedelics and Personality. ACS Chemical Neuroscience, 9( 10), 2304-2306. doi:10.1021/acschemneuro.8b00237
NLM
Aixalà M, Santos RG dos, Hallak JEC, Bouso JC. Psychedelics and Personality [Internet]. ACS Chemical Neuroscience. 2018 ; 9( 10): 2304-2306.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1021/acschemneuro.8b00237
Vancouver
Aixalà M, Santos RG dos, Hallak JEC, Bouso JC. Psychedelics and Personality [Internet]. ACS Chemical Neuroscience. 2018 ; 9( 10): 2304-2306.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1021/acschemneuro.8b00237
Artigo de periodico
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (2018)
Fontes, Fernanda Palhano; Barreto, Dayanna; Onias, Heloisa; Andrade, Kátia C; Novaes, Morgana M; Pessoa, Jessica A; Rolim, Sergio A. Mota; Osório, Flávia de Lima; Sanches, Rafael; Santos, Rafael G. dos; Tofoli, Luís Fernando; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Riba, Jordi; Santos, Francisco R; Silva Junior, Antonio A; Alchieri, João C; Coelho, Nicole L. Galvão; Soares, Bruno Lobão; Hallak, Jaime Eduardo Cecílio; Arcoverde, Emerson; Oliveira, João P. Maia de; Araújo, Dráulio B de
Fonte: Psychological Medicine. Unidades: FMRP, FCF
Assuntos: ALUCINOGÊNICOS, DEPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTES, Fernanda Palhano et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological Medicine, v. 49, n. 4, p. 655-663, 2018Tradução . . Disponível em: https://doi.org/10.1017/S0033291718001356. Acesso em: 24 ago. 2024.
APA
Fontes, F. P., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., et al. (2018). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological Medicine, 49( 4), 655-663. doi:10.1017/S0033291718001356
NLM
Fontes FP, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Rolim SAM, Osório F de L, Sanches R, Santos RG dos, Tofoli LF, Silveira G de O, Yonamine M, Riba J, Santos FR, Silva Junior AA, Alchieri JC, Coelho NLG, Soares BL, Hallak JEC, Arcoverde E, Oliveira JPM de, Araújo DB de. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial [Internet]. Psychological Medicine. 2018 ; 49( 4): 655-663.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1017/S0033291718001356
Vancouver
Fontes FP, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Rolim SAM, Osório F de L, Sanches R, Santos RG dos, Tofoli LF, Silveira G de O, Yonamine M, Riba J, Santos FR, Silva Junior AA, Alchieri JC, Coelho NLG, Soares BL, Hallak JEC, Arcoverde E, Oliveira JPM de, Araújo DB de. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial [Internet]. Psychological Medicine. 2018 ; 49( 4): 655-663.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1017/S0033291718001356
Artigo de periodico
Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model (2018)
Callejas, G. H.; Figueira, R. L.; Gonçalves, F. L. L.; Volpe, F. A. P.; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Sbragia, Lourenço
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: CANABINOIDES, DIAGNÓSTICO PRÉ-NATAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALLEJAS, G. H. et al. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, v. 51, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20177132. Acesso em: 24 ago. 2024.
APA
Callejas, G. H., Figueira, R. L., Gonçalves, F. L. L., Volpe, F. A. P., Zuardi, A. W., Crippa, J. A. de S., et al. (2018). Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, 51( 5). doi:10.1590/1414-431x20177132
NLM
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 ago. 24 ] Available from: https://doi.org/10.1590/1414-431x20177132
Vancouver
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 ago. 24 ] Available from: https://doi.org/10.1590/1414-431x20177132
Artigo de periodico
Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload (2018)
Silva, Vanessa Kappel da; Freitas, Betânia Souza de; Garcia, Rebeca Carvalho Lacerda; Monteiro, Ricardo Tavares; Hallak, Jaime Eduardo Cecílio ; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Schröder, Nadja
Fonte: Translational Psychiatry. Unidade: FMRP
Assuntos: CANABINOIDES, COGNIÇÃO, FERRO, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vanessa Kappel da et al. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Translational Psychiatry, v. 8, n. 1, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41398-018-0232-5. Acesso em: 24 ago. 2024.
APA
Silva, V. K. da, Freitas, B. S. de, Garcia, R. C. L., Monteiro, R. T., Hallak, J. E. C., Zuardi, A. W., et al. (2018). Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Translational Psychiatry, 8( 1). doi:10.1038/s41398-018-0232-5
NLM
Silva VK da, Freitas BS de, Garcia RCL, Monteiro RT, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload [Internet]. Translational Psychiatry. 2018 ; 8( 1):[citado 2024 ago. 24 ] Available from: https://doi.org/10.1038/s41398-018-0232-5
Vancouver
Silva VK da, Freitas BS de, Garcia RCL, Monteiro RT, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload [Internet]. Translational Psychiatry. 2018 ; 8( 1):[citado 2024 ago. 24 ] Available from: https://doi.org/10.1038/s41398-018-0232-5
Artigo de periodico
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain (2018)
Diana, Mariana C.; Peres, Fernanda F.; Justi, Veronica; Bressan, Rodrigo A.; Lacerda, Acioly L. T.; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Abilio, Vanesssa Costhek
Fonte: CNS Neuroscience and Therapeutics. Unidade: FMRP
Assuntos: ESQUIZOFRENIA, RATOS, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIANA, Mariana C. et al. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, v. 24, n. 7, p. 624-632, 2018Tradução . . Disponível em: https://doi.org/10.1111/cns.12852. Acesso em: 24 ago. 2024.
APA
Diana, M. C., Peres, F. F., Justi, V., Bressan, R. A., Lacerda, A. L. T., Crippa, J. A. de S., et al. (2018). Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, 24( 7), 624-632. doi:10.1111/cns.12852
NLM
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1111/cns.12852
Vancouver
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1111/cns.12852
Artigo de periodico
Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia (2018)
Peres, Fernanda Fiel; Diana, Mariana C.; Levin, Raquel; Suiama, Mayra Akimi; Almeida, Valéria; Vendramini, Ana M.; Santos, Camila M.; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa Costhek
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, ESQUIZOFRENIA, SEROTONINA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda Fiel et al. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00901. Acesso em: 24 ago. 2024.
APA
Peres, F. F., Diana, M. C., Levin, R., Suiama, M. A., Almeida, V., Vendramini, A. M., et al. (2018). Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00901
NLM
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00901
Vancouver
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00901
Artigo de periodico
Cannabidiol as a promising strategy to treat and prevent movement disorders? (2018)
Peres, Fernanda Fiel; Lima, Alvaro da Costa; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Silva, Regina H.; Abilio, Vanessa Costhek
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: DOENÇA DE PARKINSON, CANABINOIDES, DISCINESIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda Fiel et al. Cannabidiol as a promising strategy to treat and prevent movement disorders?. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00482. Acesso em: 24 ago. 2024.
APA
Peres, F. F., Lima, A. da C., Hallak, J. E. C., Crippa, J. A. de S., Silva, R. H., & Abilio, V. C. (2018). Cannabidiol as a promising strategy to treat and prevent movement disorders? Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00482
NLM
Peres FF, Lima A da C, Hallak JEC, Crippa JA de S, Silva RH, Abilio VC. Cannabidiol as a promising strategy to treat and prevent movement disorders? [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00482
Vancouver
Peres FF, Lima A da C, Hallak JEC, Crippa JA de S, Silva RH, Abilio VC. Cannabidiol as a promising strategy to treat and prevent movement disorders? [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00482
Artigo de periodico
No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study (2018)
Linares, Ila Marques Porto; Guimarães, Francisco Silveira; Eckeli, Alan Luiz; Crippa, Ana C. S.; Zuardi, Antônio Waldo; Souza, José Dalmo Silva de; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, POLISSONOGRAFIA, NEUROPSIQUIATRIA, CICLO VIGÍLIA-SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINARES, Ila Marques Porto et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00315. Acesso em: 24 ago. 2024.
APA
Linares, I. M. P., Guimarães, F. S., Eckeli, A. L., Crippa, A. C. S., Zuardi, A. W., Souza, J. D. S. de, et al. (2018). No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00315
NLM
Linares IMP, Guimarães FS, Eckeli AL, Crippa ACS, Zuardi AW, Souza JDS de, Hallak JEC, Crippa JA de S. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00315
Vancouver
Linares IMP, Guimarães FS, Eckeli AL, Crippa ACS, Zuardi AW, Souza JDS de, Hallak JEC, Crippa JA de S. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: a randomized, double-blind, placebo-controlled, crossover study [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 ago. 24 ] Available from: https://doi.org/10.3389/fphar.2018.00315

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos